ADCT-402, a PBD dimer–containing antibody drug conjugate targeting CD19-expressing malignanciesFrancesca Zammarchi, Patrick H. van Berkel(Unknown)BloodJanuary 3, 201810.1182/blood-2017-10-813493Cited by 180SaveCiteExport RISWatch citationsRelated PapersA patient-derived T cell lymphoma biorepository uncovers pathogenetic mechanisms and host-related therapeutic vulnerabilities|Cell Reports Medicine|2025|8